Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization.

Macular edema can contribute to visual loss in the retinitis pigmentosa (RP), but the sites and mechanism of blood-retinal barrier (BRB) breakdown leading to macular edema are not known. An understanding of the mechanisms involved could lead to the design of effective pharmacologic therapy to prevent or minimize macular edema in RP. To investigate this problem, immunohistochemical staining for albumin was performed on paraffin sections of 22 normal and 29 RP-affected eyes. Specimens were graded for extent of albumin extravasation in different regions of the retina, optic nerve head, ciliary body, and iris. Electron microscopic immunocytochemical staining for albumin was performed on an additional 6 normal and 9 RP-affected eyes. Two-thirds of the eyes from patients with RP and no other ocular disorders demonstrated extravascular albumin in the inner portion of the posterior retina. This was evident even in the absence of cystoid macular edema (CME), but eyes that had CME showed extensive BRB failure. In some cases, passage of albumin from the choroid to the retina was prevented even in the absence of the retinal pigment epithelium (RPE). Electron microscopic immunocytochemistry revealed that albumin permeated retinal vascular endothelial cells and RPE cells that showed degenerative changes in RP.

[1]  E. Choromokos,et al.  Cystoid macular edema in retinitis pigmentosa. , 1977, Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology.

[2]  P. Campochiaro,et al.  Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition. , 1993, Experimental eye research.

[3]  P. Campochiaro,et al.  Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics. , 1989, The American journal of pathology.

[4]  G. Fishman,et al.  Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. , 1989, Archives of ophthalmology.

[5]  T. Prager,et al.  The influence of vitreous change on vitreous fluorophotometry. , 1982, Archives of ophthalmology.

[6]  A. Bird,et al.  Retinitis pigmentosa and retinal oedema. , 1978, The British journal of ophthalmology.

[7]  P. Campochiaro,et al.  Localization of blood-retinal barrier breakdown in human pathologic specimens by immunohistochemical staining for albumin. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[8]  P. Campochiaro,et al.  Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[9]  S. Piermarocchi,et al.  Retinal fluorescein leakage in retinitis pigmentosa. , 1986, American journal of ophthalmology.

[10]  J. Marshall Pathologic Findings and Putative Mechanisms in Retinitus Pigmentosa , 1988 .

[11]  G. Fishman,et al.  Foveal lesions seen in retinitis pigmentosa. , 1977, Archives of ophthalmology.

[12]  M. Küchle,et al.  Quantifizierung von Störungen der Blut-Kammerwasser-Schranke bei Retinopathia pigmentosa - Erste Ergebnisse , 1994 .

[13]  M. Marmor,et al.  Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa. , 1994, Ophthalmology.

[14]  P. Campochiaro,et al.  An adenosine agonist and prostaglandin E1 cause breakdown of the blood-retinal barrier by opening tight junctions between vascular endothelial cells. , 1992, Investigative ophthalmology & visual science.

[15]  A. Milam,et al.  Histopathology of bone spicule pigmentation in retinitis pigmentosa. , 1995, Ophthalmology.

[16]  E. Berson,et al.  Fluorescein angiography of hereditary retinal degenerations. , 1969, Archives of ophthalmology.